ASCO 2021
In-depth coverage of the ASCO 2021 Annual Meeting
The implementation notably reduced the number of opioids that patients were prescribed.
The risk of disease recurrence is high among patients with muscle-invasive urothelial carcinoma following radical surgery.
In the study, a total of 117 men underwent 18F-DCFPyL-PET/CT.
Staging with PSMA-PET/CT and response classification by Response Evaluation Criteria had prognostic value in prostate cancer.
Assessing germline variants in patients who did and did not meet the NCCN 2019 PCa germline genetic testing criteria.
Evaluating efficacy of a cancer peptide vaccine plus pembrolizumab for locally advanced or metastatic urothelial carcinoma.
Evaluating the effects of low household income on diagnosis, goals of care, and treatment choice in prostate cancer patients.
Researchers evaluated patients with localized MIBC in clinical stages T2-4a who had no contraindications to immunotherapy.
Racial disparities have been identified in prostate MRI and may affect outcomes for Black men with prostate cancer.
A study evaluated trends in outpatient prostate cancer throughout the COVID-19 pandemic using a community-based registry.
Is PSMA expression is a reliable predictor of response to Lu-177 PSMA in patients with castration-resistant prostate cancer?
Advertisement
Advertisement
